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Social anxiety disorder (SAD) is a serious, disabling and prevalent
anxiety disorder, with a chronic course and a complex pathophysiol-
ogy [1]. Treatment for the disorder is often only moderately effective,
so insight in the neurobiological alterations underlying the condition
is pivotal in order to improve therapeutic interventions in clinical
practice [2]. In the last decade, several neuroimaging studies have
explored differences in brain structure between patients with SAD
and healthy control participants, for example by employing a mega-
analytical approach on an international multi-center dataset of MRI
data [3]. In addition, qualitative reviews and quantitative meta-anal-
yses, based on the results of patient-control studies with relatively
small sample sizes, have shed light on changes in gray matter volume
in SAD [4,5]. These studies point at differences in brain structure in
various subcortical (for example, putamen and thalamus) and cortical
brain regions (including prefrontal areas, regions of the parietal cor-
tex and temporal areas), but the results are, until now, heteroge-
neous, probably due to methodological differences with respect to
the analyses, as well as to variations in clinical characteristics like
psychiatric comorbidity and treatment (either by pharmacological
drugs or cognitive behavioral therapy).
Given the diverse findings of studies on this matter, the recent
research article published in EBioMedicine by Zhang et al. [6] entails a
relevant addition to the field and has the potential to provide addi-
tional insights into the neurobiology of the disorder. The authors
investigated gray matter characteristics between patients with SAD
and an age- and gender-matched group of healthy controls (n = 32 in
both groups) [6], extending previous studies in two ways. First, the
sample included SAD patients without comorbidity who were treat-
ment-naive, so variations in brain structure due to comorbidity
and treatment were most likely excluded. Second, the authors
used the software package FreeSurfer to investigate two distinct* Correspondence to: Department of Psychiatry, Leiden University Medical Center,
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ness (CT) and cortical surface area (CSA). Distinguishing between
these parameters is important, given their divergent developmental
trajectories and distinct genetic underpinnings  which is relevant
given the genetic background of SAD [7]. For example, an endophe-
notype study involving families genetically enriched for SAD revealed
widespread alterations in cortical gray matter characteristics which
were associated with the level of social anxiety symptoms, but did
not find overlap in regions showing changes in CT and CSA [8]. So,
investigating CT and CSA separately most likely leads to better
insights in the underlying neurobiological alterations, in comparison
to examining just gray matter volume alone.
Interestingly, the results of the study indicated changes in CT and
CSA in mainly the same brain area: patients with SAD had thinner (so
lower CT) but more expanded (larger CSA) cortical gray matter in the
bilateral prefrontal cortex (PFC). In addition, patients had increased CSA
in the left superior temporal gyrus (STG), without alterations in CT in
this region [6]. These findings suggest that SAD is associated with corti-
cal reorganization in regions functionally implicated in emotion proc-
essing and decision making (PFC), and processing social knowledge
(STG). Furthermore, the authors reported an inverse relationship
between CSA in the superior frontal gyrus (part of the PFC) and duration
of SAD. However, due to the cross-sectional nature of the study and the
fact that age of onset in SAD is often hard to assess retrospectively due
to the generally gradual progressive course of the disorder during child-
hood and adolescence, a development based on an innate vulnerability
to SAD [1,7], this finding needs to be interpreted with caution.
Despite these meaningful results concerning brain structure in
SAD, which to a large extent coincide with reported functional altera-
tions related to the disorder [4], several important questions are still
unanswered, providing directions for future studies. First, given the
high comorbidity rate in patients with SAD, it needs to be elucidated
to what extent the findings of the present study [6], involving a
unique sample of non-comorbid never-treated patients, apply to the
more general group of SAD patients who often suffer from comorbid
psychopathology like other anxiety disorders, depression and sub-
stance abuse. Furthermore, the analyses by Zhang et al. [6] did not
reveal associations between characteristics of brain structure and
symptoms, while several other studies have reported such symptom-
brain correlations, as well as on changes in brain structure related to
treatment [2,7]. Next, while the SAD-related alterations reported by
Zhang et al. are restricted to two brain areas, other work in the field
have revealed far more extended changes in brain structure [2,4,5,8].
These inconsistent findings stress the need for replication studies.the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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ENIGMA (Enhancing NeuroImaging Genetics by Meta-Analysis) con-
sortium, are of importance, as they have the potential to test the
reproducibility and robustness of neuroimaging findings [9]. As out-
lined in a recent review paper, the ENIGMA-Anxiety working group,
which has a subgroup devoted to unraveling the neurobiology of
SAD, has much potential to address such questions [10].
Taken together, the findings of Zhang et al. [6] as well as those of
other recent papers in this field indicate the importance of consider-
ing gray matter in understanding the neurobiology of SAD. Given the
diverse findings to date, we are convinced that we have not heard
the last of this, and future research involving large sample sizes is
highly warranted [10].
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